Purdue Pharma Pleads Guilty to Criminal Misbranding, $600M Fine, Zero Executives Jailed
On May 10, 2007, Purdue Pharma pleaded guilty to a felony charge of illegally misbranding OxyContin in an effort to mislead and defraud physicians and agreed to pay $600 million—representing approximately 90 percent of OxyContin profits during the offense period. The company admitted to misleading …
Purdue Pharma
Michael Friedman
Howard R. Udell
Paul D. Goldenheim
U.S. Department of Justice
opioid-crisis
corporate-crime
accountability-failure
deferred-prosecution
regulatory-capture
+1 more
Read more →